HEALEY ALS Platform Trial - Regimen B Verdiperstat

Investigator: Stanley Appel, MD

Study Coordinator:

Status: Enrolling

ClinicalTrials.gov Number: NCT04436510


Protocol Number: PRO00025615


The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen B will evaluate the safety and efficacy of a single study drug, verdiperstat, in participants with ALS.
More to Explore